spacer
home > ebr > spring 2019 > ecoa technology in vaccine clinical trials
PUBLICATIONS
European Biopharmaceutical Review

eCOA Technology in Vaccine Clinical Trials

Immunisation is one of the most successful and cost-effective public health interventions, protecting individuals against several serious, preventable, and sometimes, deadly contagious diseases, with a common example being the measles, mumps, and rubella vaccine. As essential as they are for preventative healthcare, vaccines are facing challenges in clinical trials and the industry is responsible for moving them faster through the process.

Vaccine developments face similar challenges to other therapeutic areas such as processing large volumes of manual data, which can be costly, time-consuming, and inefficient. Additionally, vaccine clinical trials often have aggressive timelines, and sponsors require a cost-effective and robust solution for data collection. By integrating electronic clinical outcome assessment (eCOA) with existing technologies, researchers can reduce the burden for study teams, increase patient compliance and retention, and improve overall study outcomes – quickly. Making the switch from traditional paperbased processes to an eCOA solution in a vaccine trial can offer many tangible benefits.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Katie Garner is the Therapeutic Areas Advisor at CRF Bracket. She is responsible for providing specific therapeutic advice and supporting the therapeutic, sales, marketing and product development teams. Previously, Katie worked as a Project Manager for a Health Outcomes Consultancy and at the NHS Purchasing and Supply Agencies Centre for Evidence-Based Purchasing. She also worked for the Medicine and Healthcare products Regulatory Agency as a Senior Medical Device Specialist, where she was responsible for the safety and regulation of in vitro diagnostic and contraceptive medical devices.
spacer
Katie Garner
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal, the global name in temperature controlled packaging, will highlight the rise of reusable temperature controlled packaging as guest speakers at Clinical Trial Supply Europe, being held in Milan on March 13 – 14, 2019.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement